Bethesda, MD, United States of America

Nuria Carrillo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by National Institute of Health. Active years: 2019.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Nuria Carrillo: Pioneering Sialylation-Increasing Therapies

Introduction

Nuria Carrillo is a distinguished inventor based in Bethesda, MD (US). She has made significant contributions to the field of medical therapies, particularly in addressing diseases associated with oxidative stress. Her innovative approaches have the potential to improve the quality of life for individuals suffering from various vascular and cardiac disorders.

Latest Patents

Nuria Carrillo holds a patent for "Sialylation-increasing therapies for diseases associated with oxidative stress." This patent outlines methods for treating subjects with vascular or cardiac disorders linked to oxidative stress. Additionally, it includes treatments for GNE myopathy, which is characterized by impaired cardiac function. The methods involve administering therapeutically effective amounts of specific acids or sialylated compounds, such as mannosamine and N-acetyl mannosamine, or their derivatives. Furthermore, the patent also describes methods for detecting disorders associated with oxidative stress.

Career Highlights

Nuria Carrillo is affiliated with the National Institutes of Health, where she contributes her expertise to advance medical research and therapeutic development. Her work is instrumental in exploring innovative solutions for complex health issues, particularly those related to oxidative stress.

Collaborations

Nuria collaborates with esteemed colleagues, including Marjan Huizing and May C Malicdan. These partnerships enhance her research efforts and contribute to the advancement of medical therapies.

Conclusion

Nuria Carrillo's innovative work in sialylation-increasing therapies showcases her commitment to improving health outcomes for patients with oxidative stress-related disorders. Her contributions to the field are invaluable and highlight the importance of continued research and innovation in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…